Capstone Capital Management Ltd Acquires 2,653 Shares of Astera Labs, Inc. $ALAB

Capstone Capital Management Ltd bought a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the third quarter, according to its most recent filing with the SEC. The firm bought 2,653 shares of the company’s stock, valued at approximately $944,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of ALAB. Keating Financial Advisory Services Inc. acquired a new position in Astera Labs during the 2nd quarter worth $25,000. Archer Investment Corp acquired a new stake in shares of Astera Labs in the second quarter valued at about $30,000. Transamerica Financial Advisors LLC acquired a new stake in shares of Astera Labs in the second quarter valued at about $35,000. Continuum Advisory LLC acquired a new stake in shares of Astera Labs in the second quarter valued at about $37,000. Finally, GK Wealth Management LLC bought a new position in shares of Astera Labs in the third quarter worth about $29,000. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Price Performance

NASDAQ ALAB opened at $284.80 on Wednesday. The firm has a market capitalization of $49.41 billion, a price-to-earnings ratio of 140.99 and a beta of 3.68. The company’s fifty day moving average is $313.70 and its two-hundred day moving average is $300.89. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The business had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the business earned $0.44 earnings per share. The firm’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, sell-side analysts expect that Astera Labs, Inc. will post 2.70 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on the company. TD Cowen cut their price objective on Astera Labs from $375.00 to $300.00 and set a “hold” rating for the company in a research report on Monday. Needham & Company LLC increased their target price on Astera Labs from $260.00 to $425.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. Roth Capital reaffirmed a “buy” rating and issued a $450.00 target price on shares of Astera Labs in a report on Wednesday, August 5th. Bank of America lifted their price target on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Finally, Weiss Ratings raised Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Eleven analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $344.17.

Insider Activity

In related news, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total transaction of $51,263,790.00. Following the transaction, the director directly owned 253,863 shares in the company, valued at $71,114,642.19. The trade was a 41.89% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 408,558 shares of company stock valued at $127,306,034. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Profile

Astera Labs, Inc is a semiconductor and connectivity solutions company that develops hardware and software for data centers, cloud computing, and artificial intelligence infrastructure. Its products are designed to help move data between processors, memory, storage, and networking components while addressing bandwidth, latency, and system-management requirements.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) Smart Retimers, Taurus Ethernet Smart Cable Modules, Scorpio Smart Fabric Switches, and Leo CXL Memory Connectivity Controllers.